Study: J&J Vaccine Reduces COVID-19 Related Deaths

A new study showed the Johnson & Johnson (JNJ.N) COVID-19 vaccine is effective by at least 90% in reducing the number of deaths linked to COVID-19, Sputnik cited Reuters on Friday.

The study has been conducted only in South Africa, and it included 477,234 vaccinated health workers. The vaccine was approved by the South African major medical regulator last April, alongside the Pfizer vaccine.

Glenda Gray, the lead researcher of the study, told Reuters that the single-shot vaccine was effective for reducing COVID-19 linked deaths by more than 91%. On the other hand, it was effective by 67% against infection.

She highlighted: "Consistently after receiving the vaccine, there was very little death occurring in the vaccinated group as compared to the control group and showing a remarkable up-to 96.2% protection against death," adding, "This was our primary endpoint and we are able to say this vaccine protected health workers against death," she added.